Login to Your Account

Praecis Gets First Approval: Plenaxis In Prostate Cancer

By Aaron Lorenzo

Monday, December 1, 2003
Prostate cancer patients gained a new treatment option on Nov. 25 as the FDA approved Plenaxis, a drug fully developed by Praecis Pharmaceuticals Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription